z-logo
open-access-imgOpen Access
A Novel Gene “Niban” Upregulated in Renal Carcinogenesis: Cloning by the cDNA‐amplified Fragment Length Polymorphism Approach
Author(s) -
Majima Shuichi,
Kajino Kazunori,
Fukuda Tomokazu,
Otsuka Fujio,
Hino Okio
Publication year - 2000
Publication title -
japanese journal of cancer research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.035
H-Index - 141
eISSN - 1349-7006
pISSN - 0910-5050
DOI - 10.1111/j.1349-7006.2000.tb01027.x
Subject(s) - carcinogenesis , microbiology and biotechnology , biology , gene , renal cell carcinoma , complementary dna , mutant , cloning (programming) , genetics , pathology , medicine , computer science , programming language
A modified AFLP (amplified fragment length polymorphism) method was employed to isolate genes differentially expressed in renal carcinogenesis of Tsc2 gene mutant (Eker) rats. One gene, selected for further investigation, was named “Niban” (“second” in Japanese), because it is the second new gene to be found after Erc (expressed in renal carcinoma) in our laboratory. Importantly, “Niban” is well expressed even in small primary rat Eker renal tumors, more than in progressed cell lines, and is also expressed in human renal carcinoma cells, but not in normal human or rat kidneys. Chromosome assignment was to RNO 13 in the rat, and HSA 1. This “Niban” gene is a candidate as a marker for renal tumor, especially early‐stage renal carcinogenesis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here